Literature DB >> 1967430

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

V Beral1, T A Peterman, R L Berkelman, H W Jaffe.   

Abstract

In the United States Kaposi's sarcoma is at least 20,000 times more common in persons with acquired immunodeficiency syndrome (AIDS) than in the general population and 300 times more common than in other immunosuppressed groups. Among persons with the acquired immunodeficiency syndrome (AIDS) reported to Centers for Disease Control by March 31, 1989, 15% (13,616) had Kaposi's sarcoma. Kaposi's sarcoma was commoner among those who had acquired the human immunodeficiency virus (HIV) by sexual contact than parenterally, the percentage with Kaposi's sarcoma ranging from 1% in men with haemophilia to 21% in homosexual or bisexual men. Women were more likely to have Kaposi's sarcoma if their partners were bisexual men rather than intravenous drug users. Kaposi's sarcoma risk was not consistently related to age or race but varied across the United States, being greatest in the areas that were the initial foci of the AIDS epidemic. Thus Kaposi's sarcoma in persons with AIDS may be caused by an as yet unidentified infectious agent, transmitted mainly by sexual contact.

Entities:  

Mesh:

Year:  1990        PMID: 1967430     DOI: 10.1016/0140-6736(90)90001-l

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  194 in total

1.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Does risk factor epidemiology put epidemiology at risk? Peering into the future.

Authors:  M Susser
Journal:  J Epidemiol Community Health       Date:  1998-10       Impact factor: 3.710

3.  Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Authors:  Brian R Lane; Jianguo Liu; Paul J Bock; Dominique Schols; Michael J Coffey; Robert M Strieter; Peter J Polverini; David M Markovitz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.

Authors:  Dong Ta Zhong; Chun Mei Shi; Qiang Chen; Jing Ze Huang; Jian Gang Liang; Dong Lin
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-11       Impact factor: 4.553

6.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

7.  Meeting report. Report of meeting of Section of Clinical Immunology and Allergy, 11 March 1991.

Authors: 
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 5.344

8.  And then there were eight...

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1996-01

9.  Epidemiology of reported cases of AIDS in lesbians, United States 1980-89.

Authors:  S Y Chu; J W Buehler; P L Fleming; R L Berkelman
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

10.  Non AIDS Kaposi's Sarcoma Leading to Lower Extremities Wounds, Case Presentations and Discussion.

Authors:  Laemthong Phavixay; David Raynolds; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.